Publications in collaboration with researchers from Hospital Vall d'Hebron (20)

2024

  1. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 16-22

  2. Lung Function and Symptoms of Exposure to the Volcanic Eruption in the Canary Islands: First Follow-Up of the ASHES Study

    Archivos de Bronconeumologia, Vol. 60, Núm. 8, pp. 475-482

  3. Occupational Exposures, Chronic Obstructive Pulmonary Disease and Tomographic Findings in the Spanish Population

    Toxics, Vol. 12, Núm. 10

2022

  1. ANTES Program: One Year on

    Archivos de Bronconeumologia

  2. [Translated article] ANTES Program: One Year on

    Archivos de Bronconeumologia

2021

  1. Prevalence and Determinants of COPD in Spain: EPISCAN II

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 61-69

2020

  1. Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10

2019

  1. 10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain —A Summary of the EPISCAN II Protocol

    Archivos de Bronconeumologia, Vol. 55, Núm. 1, pp. 38-47

2018

  1. Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes

    Archivos de Bronconeumologia, Vol. 54, Núm. 11, pp. 559-567

2017

  1. A simple algorithm for the identification of clinical COPD phenotypes

    European Respiratory Journal, Vol. 50, Núm. 5

  2. Algorithm for identification of asthma - COPD overlap: Consensus between the Spanish COPD and asthma guidelines

    European Respiratory Journal

  3. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

    Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24

  4. Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase

    Archivos de Bronconeumologia, Vol. 53, Núm. 6, pp. 324-335

  5. The variability of respiratory symptoms and associated factors in COPD

    Respiratory Medicine, Vol. 129, pp. 165-172

2016

  1. Prognostic assessment in COPD without lung function: The B-AE-D indices

    European Respiratory Journal, Vol. 47, Núm. 6, pp. 1635-1644

2015

  1. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: A pooled analysis of individual patient data

    The Lancet Respiratory Medicine, Vol. 3, Núm. 6, pp. 443-450

  2. What pulmonologists think about the asthma–COPD overlap syndrome

    International Journal of COPD, Vol. 10, pp. 1321-1330

  3. «Correct Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease»: A Consensus Document

    Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 193-198

2014

  1. Finding the best thresholds of FEV1and dyspnea to predict 5-year survival in COPD patients: The COCOMICS study

    PLoS ONE, Vol. 9, Núm. 2

2013

  1. Multicomponent indices to predict survival in COPD: The COCOMICS study

    European Respiratory Journal, Vol. 42, Núm. 2, pp. 323-332